Hosted on MSN1mon
What Happened To The Controversial Jardiance Commercial Lady?
Jardiance sparked controversy with their commercial starring Deanna Colón that originally aired in April 2023. The ad featured Colón singing and dancing while discussing the diabetes medication.
With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients
Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.
pharmaphorum2d
Jardiance doesn’t cut it in post-heart attack trial
The EMPACT-MI trial found that giving Boehringer Ingelheim and Eli Lilly’s SGLT2 drug Jardiance (empagliflozin) within 14 days of an acute myocardial infarction (AMI) reduced the risk of a ...
Verywell Health on MSN11mon
Jardiance vs. Farxiga: Similarities and Differences
Farxiga (dapagliflozin) and Jardiance (empagliflozin) are prescription medications that are commonly used for type 2 diabetes ...
pharmaphorum3y
Jardiance pulls ahead of Forxiga with heart failure approval in EU
Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has become the first drug in the class to be approved in the EU for all adults with symptomatic chronic heart failure (CHF), giving ...